Injective, a decentralized finance (DeFi) app platform, has shared exciting news that they plan to stake 50% of the total supply of INJ tokens. In a recent post on January 15, Injective highlighted the remarkable growth of its monthly staking protocol.
CryptosHeadlines Platform Has Launched its Native token Get Waitlisted Now on https://cryptosheadlinestoken.com/
As of January 14, over 47.7 million tokens are being staked, making up 47.7% of the total supply. The current Annual Percentage Rate (APR) is nearly 16%, specifically 15.96%. Over the past month, there has been a consistent rise in the total staking volume, coupled with an increase in new delegates joining the platform.
Injective’s Staking Milestone and Expert Insights
In response to recent data, the Injective team has made a commitment to stake half of all available tokens in the near future. Notably, a cryptocurrency expert, commenting on the post, highlighted the impressive growth of INJ’s staking share, underscoring its significance as a pivotal moment in the network’s decentralization journey. Should the protocol successfully surpass the 50% staked milestone, it holds the potential for profound implications for token holders and an overall enhancement of the ecosystem’s security.
Injective’s Major Mainnet Update and HKVAC Recognition
Last week, Injective introduced a substantial mainnet update named Volan, with a focus on enhancing scalability, compatibility, and various additional improvements. Regarded by developers as one of the most significant updates in the project’s history, Volan is anticipated to attract more users and accelerate the overall development of the Injective ecosystem.
Adding to the positive developments, The Hong Kong Virtual Asset Rating Agency (HKVAC) has included INJ in its latest list after recent index adjustments. Renowned for rating digital asset trading platforms and crypto market indexes, HKVAC stands as a notable barometer reflecting ongoing shifts in the cryptocurrency market.
Important: Please note that this article is only meant to provide information and should not be taken as legal, tax, investment, financial, or any other type of advice.
